These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18347209)

  • 1. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction.
    Degousee N; Fazel S; Angoulvant D; Stefanski E; Pawelzik SC; Korotkova M; Arab S; Liu P; Lindsay TF; Zhuo S; Butany J; Li RK; Audoly L; Schmidt R; Angioni C; Geisslinger G; Jakobsson PJ; Rubin BB
    Circulation; 2008 Apr; 117(13):1701-10. PubMed ID: 18347209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of microsomal prostaglandin E(2) synthase-1 in bone marrow-derived myeloid cells impairs left ventricular function and increases mortality after acute myocardial infarction.
    Degousee N; Simpson J; Fazel S; Scholich K; Angoulvant D; Angioni C; Schmidt H; Korotkova M; Stefanski E; Wang XH; Lindsay TF; Ofek E; Pierre S; Butany J; Jakobsson PJ; Keating A; Li RK; Nahrendorf M; Geisslinger G; Backx PH; Rubin BB
    Circulation; 2012 Jun; 125(23):2904-13. PubMed ID: 22589381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of microsomal prostaglandin E synthase-1 deletion in acute cardiac ischemia in mice.
    Wu D; Mennerich D; Arndt K; Sugiyama K; Ozaki N; Schwarz K; Wei J; Wu H; Bishopric NH; Doods H
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):31-3. PubMed ID: 19524423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of microsomal prostaglandin E synthase-1 deletion and COX-2 inhibition in acute cardiac ischemia in mice.
    Wu D; Mennerich D; Arndt K; Sugiyama K; Ozaki N; Schwarz K; Wei J; Wu H; Bishopric NH; Doods H
    Prostaglandins Other Lipid Mediat; 2009 Nov; 90(1-2):21-5. PubMed ID: 19559811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid Cell mPges-1 Deletion Attenuates Mortality Without Affecting Remodeling After Acute Myocardial Infarction in Mice.
    Chen L; Yang G; Jiang T; Tang SY; Wang T; Wan Q; Wang M; FitzGerald GA
    J Pharmacol Exp Ther; 2019 Jul; 370(1):18-24. PubMed ID: 30992314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
    Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion.
    Harding P; Yang XP; He Q; Lapointe MC
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1053-61. PubMed ID: 21193590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.
    Wang M; Lee E; Song W; Ricciotti E; Rader DJ; Lawson JA; Puré E; FitzGerald GA
    Circulation; 2008 Mar; 117(10):1302-9. PubMed ID: 18285567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction.
    Jia Z; Wang H; Yang T
    Hypertension; 2012 Jan; 59(1):122-8. PubMed ID: 22106404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice.
    Zhang Y; Steinmetz-Späh J; Idborg H; Zhu L; Li H; Rao H; Chen Z; Guo Z; Hu L; Xu C; Chen H; Korotkova M; Jakobsson PJ; Wang M
    Br J Pharmacol; 2023 Aug; 180(15):1981-1998. PubMed ID: 36788645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
    Dawson D; Lygate CA; Zhang MH; Hulbert K; Neubauer S; Casadei B
    Circulation; 2005 Dec; 112(24):3729-37. PubMed ID: 16344403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.
    Wang M; Cooper PR; Jiang M; Zhao H; Hui Y; Yao Y; Tate JC; Damera G; Lawson JA; Jester WF; Haczku A; Panettieri RA; FitzGerald GA
    J Pharmacol Exp Ther; 2010 Jul; 334(1):63-8. PubMed ID: 20371706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal Prostaglandin E
    Ji S; Guo R; Wang J; Qian L; Liu M; Xu H; Zhang J; Guan Y; Yang G; Chen L
    J Pharmacol Exp Ther; 2020 Oct; 375(1):40-48. PubMed ID: 32759273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
    Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
    Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.